Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease.

By Bezafibrate Infarction Prevention study. Circulation, 2000

1,200 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/ca4451f9e6e226ade503b40f14f162d46dbdca07

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. J. Chapman
2. A. Kontush

In Endocrinology, Diabetes and Metabolism

1. J. Chapman
2. A. Kontush

In Surgery

1. J. Chapman
2. A. Kontush

Citations in the corpus

• Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis (2006, background): “Inactivation of oxidized lipids by HDL may be associated with decreased expression of adhesion molecules in and decreased macrophage adhesion to endothelial cells (Theilmeier et al., 2000; Navab et al., 2004b).”